DCOY Decoy Therapeutics Inc.
Company Analysis
Latest News
🔴 Decoy Therapeutics is trading 5.65% down today amid broader pressure from hotter-than-expected inflation
Decoy Therapeutics is trading 5.65% down at $1.17, likely amid broader market pressure after hotter-than-expected inflation. - No confirmed company-specific...
🔴 Decoy Therapeutics is trading 10.4% down today with no confirmed company-specific catalyst identified
Decoy Therapeutics is trading at $1.28, down 10.44%, with no confirmed company-specific catalyst for the October 13 decline. - The report likewise cites no...
🔴 Decoy Therapeutics is trading 5.6% down with no confirmed catalyst
Decoy Therapeutics is trading 5.6% down at $1.35 as of 9:37 a.m. EST on October 13, 2026, with no clear company-specific announcement or confirmed catalyst...
🔴 Decoy Therapeutics is trading 6.2% down amid resale-share registration
Decoy Therapeutics is trading at $1.51, down 6.2%, as a resale-share filing may be weighing on shares, though reports do not establish it as the cause. - A...
🔴 Decoy Therapeutics is trading 5.4% down after a seven-session decline
Decoy Therapeutics is trading 5.4% down at $1.58 on October 6, following a seven-session decline from $3.09 on September 25; no clear company-specific...
🔴 Decoy Therapeutics is trading 7.2% down in pre-market; no clear company-specific catalyst identified
Decoy Therapeutics is trading at $1.55, down 7.17% in pre-market on October 6; no clearly reported company-specific catalyst has been identified. - Recent...
🔴 Decoy Therapeutics is trading 5% down; no clear October 5 catalyst identified
Decoy Therapeutics is trading at $1.68, down 5.08%, with no clear catalyst identified for the October 5, 2026 intraday decline. - Latest widely surfaced...
🔴 Decoy Therapeutics is trading 13.0% down in pre-market
Decoy Therapeutics is trading 13.0% lower at $1.54, extending a seven-session slide with no clear company-specific explanation for the October 5 pre-market...
🟢 Decoy Therapeutics is trading 11.9% up in pre-market
Decoy Therapeutics is trading at $1.98, up 11.86%, in pre-market; no clear catalyst for the October 5 rise appeared in available search results. - The latest...
🔴 Decoy Therapeutics is trading 11.6% down with no clear catalyst identified
Decoy Therapeutics is trading at $1.64, down 11.59%, with no clear company-specific catalyst identified for the October 2 decline. - The latest reported...
🔴 Decoy Therapeutics is trading 5.7% down with no clear catalyst identified
Decoy Therapeutics is trading 5.7% down at $1.75, with no clearly identified catalyst for the October 2 decline. - The latest preclinical update was reported...
🔴 Decoy Therapeutics is trading 5% down in pre-market amid mixed biotech-sector signals
Decoy Therapeutics is trading 5.12% down at $1.76, with no fresh company-specific announcement identified to explain the October 2 pre-market decline. - The...
🔴 Decoy Therapeutics is trading 7.6% down with no clear company-specific catalyst identified
Decoy Therapeutics is trading 7.6% lower at $1.82, with no clear company-specific catalyst identified for the October 1 decline. - The CEO presentation at The...
🔴 Decoy Therapeutics is trading 5.6% down with no clear catalyst identified
Decoy Therapeutics is trading at $2.01, down 5.63%; no clear catalyst was identified for the September 30 decline. - The company announced its CEO will present...
🔴 Decoy Therapeutics is trading 11% down
Decoy Therapeutics is trading at $2.06, down 10.61%, with no clear catalyst established for the decline. - On September 29, Decoy Therapeutics announced...
🔴 Decoy Therapeutics is trading 5% down
Decoy Therapeutics is trading at $2.19, down 5.41%, with no clear catalyst established. - September 29 preclinical data showed a single intranasal dose...
🟢 Decoy Therapeutics is trading 7.2% up in after-hours trading
Decoy Therapeutics is trading 7.2% higher at $2.48 after hours, with no fresh company-specific announcement identified to explain the rebound. - The stock...
🔴 Decoy Therapeutics is trading 10.68% down amid broader risk-off pressure
Decoy Therapeutics is trading at $2.76, down 10.68% on September 28, 2026, amid broader risk-off pressure; no fresh company-specific catalyst was...
🔴 Decoy Therapeutics is trading 9.39% down with no fresh company-specific catalyst identified
Decoy Therapeutics is trading 9.39% lower at $2.80, with no fresh company-specific catalyst identified for the September 28 decline. - The available alert...
🔴 Decoy Therapeutics is trading 6.8% down in pre-market with no company-specific catalyst identified
Decoy Therapeutics is trading at $2.88, down 6.80%, with no fresh company-specific catalyst identified for the September 28 pre-market drop. - Broader...